Melian Agustin 4
4 · Allovir, Inc. · Filed Jan 21, 2021
Insider Transaction Report
Form 4
Allovir, Inc.ALVR
Melian Agustin
Chief Medical Officer
Transactions
- Award
Common Stock
2021-01-19+43,750→ 575,115 total - Award
Stock Option (Right to Buy)
2021-01-19+81,250→ 81,250 totalExercise: $42.15Exp: 2031-01-19→ Common Stock (81,250 underlying)
Footnotes (2)
- [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on January 19, 2022, with the remainder vesting in twelve equal quarterly installments thereafter.
- [F2]25% of this option shall vest and become exercisable on January 19, 2022, with the remainder vesting in twelve equal quarterly installments thereafter.